Xianying Wang

No ORCID on file · 1 paper in corpus

meta-analysis 2025

A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding

Gland surgery ·doi:10.21037/gs-24-386

BACKGROUND: Elagolix is an oral small molecule second-generation nonpeptide gonadotropin-releasing hormone (GnRH) antagonist drug that can quickly and reversibly inhibit female gonadotropins and ovarian sex hormones. Previous randomized con…